PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Health Data Science Unit, Medical Faculty Heidelberg and BioQuant, Heidelberg, Germany.\', \'Department of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.\', \'Research Group \'Cellular Polarity and Viral Infection\', German Cancer Research Center (DKFZ), Heidelberg, Germany.\', \'Institute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany.\', \'Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.ppat.1009687
?:doi
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 34181691
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
is ?:relation_isRelatedTo_publication of
?:title
  • The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all